Kasner, Margaret T.
Halloran, Molly B.
Pan, Jonathan
Ritchie, Ellen K.
Fetterly, Gerald J.
Kramer, Douglas
Hangauer, David G.
Thompson, James E.
Funding for this research was provided by:
Athenex Pharmaceuticals
Article History
Received: 28 March 2022
Accepted: 10 May 2022
First Online: 17 May 2022
Declarations
:
: The study was conducted in accordance with the principles of the World Medical Association Declaration of Helsinski, the International Council on Harmonization Good Clinical Practice Guideline, the US Code of Federal Regulations dealing with clinical studies, as well as the ethical standards of the participating institutional committees.
: Written informed consent was obtained from all individual participants included in the study.
: Not Applicable.
: Douglas Kramer and David G. Hangauer were employed at Athenex Pharmaceuticals. All remaining authors declare no financial or non-financial competing interests.